Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Clinical trial NCT04759586 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04759586
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2026-12-31
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.